A detailed history of Pictet Asset Management Sa transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Pictet Asset Management Sa holds 2,063,810 shares of BMRN stock, worth $138 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,063,810
Previous 2,054,522 0.45%
Holding current value
$138 Million
Previous $200 Million 10.46%
% of portfolio
0.21%
Previous 0.25%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$86.68 - $100.3 $805,083 - $931,586
9,288 Added 0.45%
2,063,810 $179 Million
Q1 2023

May 10, 2023

BUY
$87.74 - $117.27 $50.5 Million - $67.5 Million
576,001 Added 38.96%
2,054,522 $200 Million
Q4 2022

Feb 13, 2023

BUY
$80.93 - $108.63 $57.5 Million - $77.1 Million
710,154 Added 92.42%
1,478,521 $153 Million
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $22.7 Million - $26.8 Million
276,664 Added 56.27%
768,367 $65.1 Million
Q2 2022

Aug 09, 2022

BUY
$71.48 - $86.85 $923,736 - $1.12 Million
12,923 Added 2.7%
491,703 $40.7 Million
Q1 2022

May 13, 2022

SELL
$74.28 - $92.69 $593,794 - $740,963
-7,994 Reduced 1.64%
478,780 $36.9 Million
Q4 2021

Feb 10, 2022

SELL
$71.72 - $91.47 $19.2 Million - $24.5 Million
-268,054 Reduced 35.51%
486,774 $43 Million
Q3 2021

Nov 12, 2021

BUY
$74.77 - $85.47 $56.4 Million - $64.5 Million
754,828 New
754,828 $58.3 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.